Logo image of SRGA

SURGALIGN HOLDINGS INC (SRGA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SRGA - US86882C2044 - Common Stock

0.1829 USD
-0.09 (-32.98%)
Last: 6/30/2023, 8:00:01 PM
0.1235 USD
-0.06 (-32.48%)
After Hours: 6/30/2023, 8:00:01 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SRGA. SRGA was compared to 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of SRGA have multiple concerns. SRGA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • SRGA had negative earnings in the past year.
  • In the past year SRGA has reported a negative cash flow from operations.
SRGA Yearly Net Income VS EBIT VS OCF VS FCFSRGA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 -50M -100M -150M -200M

1.2 Ratios

  • The profitability ratios for SRGA are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SRGA Yearly ROA, ROE, ROICSRGA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 200 -200 -400

1.3 Margins

  • SRGA's Gross Margin of 47.06% is in line compared to the rest of the industry. SRGA outperforms 43.00% of its industry peers.
  • In the last couple of years the Gross Margin of SRGA has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for SRGA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.98%
GM growth 5Y-0.73%
SRGA Yearly Profit, Operating, Gross MarginsSRGA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 50 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

  • SRGA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SRGA has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for SRGA is higher compared to a year ago.
SRGA Yearly Shares OutstandingSRGA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
SRGA Yearly Total Debt VS Total AssetsSRGA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M

2.2 Solvency

  • SRGA has an Altman-Z score of -14.39. This is a bad value and indicates that SRGA is not financially healthy and even has some risk of bankruptcy.
  • SRGA's Altman-Z score of -14.39 is on the low side compared to the rest of the industry. SRGA is outperformed by 85.51% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -14.39
ROIC/WACCN/A
WACC5.62%
SRGA Yearly LT Debt VS Equity VS FCFSRGA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M -100M 200M

2.3 Liquidity

  • A Current Ratio of 2.67 indicates that SRGA has no problem at all paying its short term obligations.
  • SRGA has a Current ratio of 2.67. This is in the lower half of the industry: SRGA underperforms 60.87% of its industry peers.
  • SRGA has a Quick Ratio of 2.00. This is a normal value and indicates that SRGA is financially healthy and should not expect problems in meeting its short term obligations.
  • SRGA's Quick ratio of 2.00 is in line compared to the rest of the industry. SRGA outperforms 42.03% of its industry peers.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2
SRGA Yearly Current Assets VS Current LiabilitesSRGA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

More info and screens

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 50.34% over the past year.
  • Looking at the last year, SRGA shows a very negative growth in Revenue. The Revenue has decreased by -11.04% in the last year.
  • Measured over the past years, SRGA shows a very negative growth in Revenue. The Revenue has been decreasing by -21.76% on average per year.
EPS 1Y (TTM)50.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)-11.04%
Revenue growth 3Y-11.28%
Revenue growth 5Y-21.76%
Sales Q2Q%-18.72%

3.2 Future

  • The Earnings Per Share is expected to decrease by -26.80% on average over the next years. This is quite bad
  • SRGA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.28% yearly.
EPS Next Y-58.25%
EPS Next 2Y-26.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-37.13%
Revenue Next 2Y-17.44%
Revenue Next 3Y10.86%
Revenue Next 5Y5.28%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SRGA Yearly Revenue VS EstimatesSRGA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
SRGA Yearly EPS VS EstimatesSRGA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • SRGA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year SRGA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SRGA Price Earnings VS Forward Price EarningsSRGA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SRGA Per share dataSRGA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

  • A cheap valuation may be justified as SRGA's earnings are expected to decrease with -26.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.8%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • SRGA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SURGALIGN HOLDINGS INC / SRGA FAQ

What is the ChartMill fundamental rating of SURGALIGN HOLDINGS INC (SRGA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to SRGA.


What is the valuation status of SURGALIGN HOLDINGS INC (SRGA) stock?

ChartMill assigns a valuation rating of 0 / 10 to SURGALIGN HOLDINGS INC (SRGA). This can be considered as Overvalued.


Can you provide the profitability details for SURGALIGN HOLDINGS INC?

SURGALIGN HOLDINGS INC (SRGA) has a profitability rating of 0 / 10.


Can you provide the financial health for SRGA stock?

The financial health rating of SURGALIGN HOLDINGS INC (SRGA) is 1 / 10.